curesponse.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.curesponse.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Homepage - Curesponse | Better Cancer
Description Know. Curesponse has developed a 3-dimensional tissue culture system for modeling cancer growth and drug response. The platform, preserves the cancer tissue architecture (including vasculature and immune system) accurately reflecting the cancer growth
Keywords N/A
Server Information
WebSite curesponse faviconcuresponse.com
Host IP 185.230.63.186
Location -
Related Websites
Site Rank
More to Explore
curesponse.com Valuation
US$959,505
Last updated: 2023-05-09 16:43:55

curesponse.com has Semrush global rank of 11,031,013. curesponse.com has an estimated worth of US$ 959,505, based on its estimated Ads revenue. curesponse.com receives approximately 110,713 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, curesponse.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$959,505
Daily Ads Revenue US$886
Monthly Ads Revenue US$26,571
Yearly Ads Revenue US$318,851
Daily Unique Visitors 7,381
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
curesponse.com. A 3600 IP: 185.230.63.186
curesponse.com. A 3600 IP: 185.230.63.107
curesponse.com. A 3600 IP: 185.230.63.171
curesponse.com. NS 86400 NS Record: ns6.wixdns.net.
curesponse.com. NS 86400 NS Record: ns7.wixdns.net.
curesponse.com. MX 3600 MX Record: 10 mx07.register.com.
HtmlToTextCheckTime:2023-05-09 16:43:55
About Team cResponse Technology Resources Research and Evidence Videos Pharma News & Events Contact Menu About Team cResponse Technology Resources Research and Evidence Videos Pharma News & Events Contact Know. Before. We just made cancer treatment selection even more personal Introducing cResponse™ Test up to 8 drugs, including chemo, targeted, and IO, on your patient’s 3-dimensional original tumor, and see which is the most effective. cResponse™ cResponse™ in Numbers 0 % Accuracy in predicting treatment efficacy > 0 Actionable genomic mutations 0 Drugs and drug combinations tested 0 Days from biopsy to results Watch How cResponse™ Works Next Generation in Cancer Precision Medicine As each tumor is unique, each patient will respond differently to anti-cancer therapies. While genomic sequencing of tumors can help some patients to select the right treatment, most patients will not benefit from this technology, and their response to therapy (whether selected by genomic testing or
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Mon, 01 Nov 2021 04:59:41 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.curesponse.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635742781.4509777605802922939
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhT9gRHUF6iCEZerWBFcnqX,m0j2EEknGIVUW/liY8BLLrb3eKb2faxipHpDHW1Enb4cm7On4dir39PTYYK13tG9,2d58ifebGbosy5xc+FRalkY6s7ect7C5FX/+AbnFi2bo0awLgasNRb+y72fsvo1jSeW5YVrGfbWqg+RhZcSY8g==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,WcrWvzU6+v56AFbpVWES8tzLUuaI6eLNF1eKlQ0LzQ8aWyug/ZdHQ36uOAkr89T0,adCcrjWN+9jYhIHsscsS5qoxM6AYV5yLMORRSvUecgHkrkHQJn3qjwgGUStxf9V2WIHlCalF7YnfvOr2cMPpyw==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 01 Nov 2021 04:59:41 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1635742781.606105193294614757
content-language: en
strict-transport-security: max-age=120
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMd0qnhlQ7CKiS1i9ukj0dSj,qquldgcFrj2n046g4RNSVFCyQoc+8a4IB0r6FC3J5Wc=,2d58ifebGbosy5xc+FRalkAUEsmEKvW1pwWUdFUD3Eh/X9gV/dUyzcSBnbmO3K1JSf524lPwTgDbn82fURSkbmrGoQYNt6gnPAu2JbQpk4w=,2UNV7KOq4oGjA5+PKsX47BKn5Yg4ON9Aa7djl3ltpSdYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,qJS91GsscGZlb16v+8nwmGQ6ejUeAhGbPNhCR6n3oXEPUN6zYCeYUhP+LoeE7OiY,adCcrjWN+9jYhIHsscsS5sYEMcnrGOBgM/4OnBoW7fyFhlBYX/15RZmEnd3dQZNZL6N2ln7JpxtqCGQ7leK5kA==,qJS91GsscGZlb16v+8nwmGQ6ejUeAhGbPNhCR6n3oXEPUN6zYCeYUhP+LoeE7OiY,qJS91GsscGZlb16v+8nwmMT+FskH3k6Em1IJZZQuBEEPUN6zYCeYUhP+LoeE7OiY,LoUK8/saGAmOxZWtpubo2vAE5bh/nLdVpIYSe1rPUvztjewqVuAWjFyT5Y+Q3wiJbINF/yQvCjIhdyPURkmkog==,qJS91GsscGZlb16v+8nwmMT+FskH3k6Em1IJZZQuBEEPUN6zYCeYUhP+LoeE7OiY,dvEkI3CoQ26/kOBf/eu3DA1Ax2p6/GoZVHKur29/3JkaWyug/ZdHQ36uOAkr89T0,/a5ccLSK1HEmwPNg/x6OumsrOfbn7BCcbK5Xj5WgLREdQsyfO9LC+7BWxRmvPRzZwC3HAiO41klA5tj0hrzo8w==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=usc1_g; Max-Age=20; Expires=Mon, 01 Nov 2021 05:00:01 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
curesponse.com Whois Information
Domain Name: CURESPONSE.COM
Registry Domain ID: 2171800797_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.com
Registrar URL: http://www.register.com
Updated Date: 2019-02-13T06:11:39Z
Creation Date: 2017-10-08T07:52:49Z
Registry Expiry Date: 2022-10-08T07:52:49Z
Registrar: Register.com, Inc.
Registrar IANA ID: 9
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: ok https://icann.org/epp#ok
Name Server: NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-19T14:24:28Z <<<